Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-08-001050
Filing Date
2008-03-13
Accepted
2008-03-13 16:43:07
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K w51167e10vk.htm 10-K 1163904
2 EX-3.9 w51167exv3w9.htm EX-3.9 82300
3 EX-10.22 w51167exv10w22.htm EX-10.22 72900
4 EX-23.1 w51167exv23w1.htm EX-23.1 1398
5 EX-31.1 w51167exv31w1.htm EX-31.1 8154
6 EX-31.2 w51167exv31w2.htm EX-31.2 8413
7 EX-32.1 w51167exv32w1.htm EX-32.1 4260
8 EX-32.2 w51167exv32w2.htm EX-32.2 3987
9 GRAPHIC w51167w5116702.gif GRAPHIC 8512
10 GRAPHIC w51167w5116701.gif GRAPHIC 63054
  Complete submission text file 0000950133-08-001050.txt   1445671
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51863 | Film No.: 08686624
SIC: 2834 Pharmaceutical Preparations